Patents-Review.com
ClassID:

94675 ⎘

C07D263/46 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Sulfur atoms

Recent Application in this class:
#1
20250163006
2025-05-22

New Coolants, and Preparations Containing Same

 #2
20240391884
2024-11-28

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

 #3
20240002350
2024-01-04

PROTEIN AND LIPID THERAPEUTIC TARGETS

 #4
20230416211
2023-12-28

Compounds and compositions for treating conditions associated with NLRP activity

 #5
20230416168
2023-12-28

N-HETEROCYCLIC COMPOUNDS USED AS NITRIFICATION INHIBITOR

 #6
20230103444
2023-04-06

SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER

 #7
20230099258
2023-03-30

Compounds and compositions for treating conditions associated with NLRP activity

 #8
20230079631
2023-03-16

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

 #9
20230062815
2023-03-02

Compounds and compositions for treating conditions associated with NLRP activity

 #10
20230041576
2023-02-09

METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY

 #11
20220380325
2022-12-01

ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE

 #12
20220372028
2022-11-24

Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

 #13
20210340114
2021-11-04

HETEROCYCLIC COMPOUND

 #14
20210323934
2021-10-21

4-oxazolidinone antimicrobial agents

 #15
20210230129
2021-07-29

Compounds and compositions for treating conditions associated with NLRP activity

 #16
20210171477
2021-06-10

Compounds and compositions for treating conditions associated with NLRP activity

 #17
20210070718
2021-03-11

Phenylsulfonyl oxazole derivative and use thereof

 #18
20210040078
2021-02-11

Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

 #19
20200337311
2020-10-29

FLUORALKENYL COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOF

 #20
20200247763
2020-08-06

Androgen receptor modulators and methods for their use

 #21
20200157062
2020-05-21

Heterocyclic compound

 #22
20200140425
2020-05-07

COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS

 #23
20200123146
2020-04-23

HETEROCYCLIC INTEGRIN AGONISTS

 #24
20200123117
2020-04-23

ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE

 #25
20200031816
2020-01-30

Heteroaryl compound, enantiomer, diastereomer or pharmaceutically acceptable salt thereof, and antiviral composition containing same as active ingredient

 #26
20190177285
2019-06-13

4-oxazolidinone antimicrobial agents

 #27
20190152966
2019-05-23

Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

 #28
20190119225
2019-04-25

Heterocyclic compound

 #29
20190119224
2019-04-25

Compounds and compositions for treating conditions associated with NLRP activity

 #30
20190119203
2019-04-25

Compounds and compositions for treating conditions associated with NLRP activity

 #31
20180237456
2018-08-23

Amino acid acylation reagents and methods of using the same

 #32
20180237404
2018-08-23

Heterocyclic compound

 #33
20170152262
2017-06-01

Vinylogous thioester compounds and methods of use

 #34
20160031870
2016-02-04

Compounds for the treatment of tuberculosis

 #35
20140303026
2014-10-09

Compounds for modulating integrin CD11B/CD18

 #36
20140171437
2014-06-19

Oxazole derivatives useful as inhibitors of FAAH

 #37
20130316906
2013-11-28

Phenyl-substituted bicyclooctane-1,3-dione-derivatives

 #38
20130045967
2013-02-21

Compounds for modulating integrin CD11b/CD18

 #39
20130018048
2013-01-17

Oxazole derivatives useful as modulators of FAAH

 #40
20130012526
2013-01-10

Oxazole derivatives useful as modulators of FAAH

 #41
20120108616
2012-05-03

Substituted oxazole derivatives and their use as tyrosine kinase inhibitors

 #42
20110312875
2011-12-22

Peptidic compounds

 #43
20110190125
2011-08-04

2-(BENZYLSULFONYL)OXAZOLE DERIVATIVES, CHIRAL 2-(BENZYLSULFINYL)OXAZOLE DERIVATIVES...

 #44
20110144119
2011-06-16

Oxazole derivatives useful as inhibitors of FAAH

 #45
20100210683
2010-08-19

Imidate compound and use thereof for pest control

 #46
20100075931
2010-03-25

Substituted oxazole ketone modulators of fatty acid amide hydrolase

 #47
20100056503
2010-03-04

Compounds for modulating integrin CD11b/CD18

 #48
20090275538
2009-11-05

ARYLMETHYLIDENE HETEROCYCLES AS NOVEL ANALGESICS

 #49
20090192203
2009-07-30

COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS

 #50
20090093641
2009-04-09

Synthesis of Pentafluorosulfanyl (SF5)-Substituted Heterocycles and Alkynes

 #51
20090030038
2009-01-29

Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor

 #52
20080312292
2008-12-18

Antipruritics

 #53
20080300287
2008-12-04

Peptidic compounds

 #54
20080269219
2008-10-30

Neurotrophin production/secretion promoting agent

 #55
20080266069
2008-10-30

Vehicle comprising a distance control system

 #56
20080249137
2008-10-09

PPAR active compounds

 #57
20080242704
2008-10-02

Substituted Oxazole Derivatives and their Use as Tyrosine Kinase Inhibitors

 #58
20070179180
2007-08-02

Novel m3 muscarinic acetylcholine receptor antagonists

 #59
20050101590
2005-05-12

Antipruritics

 #60
20050090534
2005-04-28

Azole compounds

 #61
20050026930
2005-02-03

PNA monomer and precursor

 #62
20050004232
2005-01-06

Acyl sulfonamides as inhibitors of HIV integrase